Catalyst Wire Dossier Catalyst Wire Dossier

Rivastigmine patch (15 cm²)

rivastigmine · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rivastigmine patch (15 cm²), covering 2024-05-31 to 2024-05-31. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type. [Phase 4]

See pricing